HOME >> BIOLOGY >> NEWS
News conference on emerging plant diseases

Event: News conference on emerging plant diseases

Find out the latest information on plant diseases that are significantly affecting the economy and the environment at a news conference on August 1, 2005 at 10 a.m. Central Time. The news conference will be held during The American Phytopathological Society (APS) Annual Meeting in Austin, Texas.

Leading plant disease experts will provide an update on the following diseases:

  • Citrus Canker
  • Bacterial Wilt
  • Plum Pox
  • Sudden Oak Death
  • Soybean Rust

    Reporters and editors will have an opportunity to address the speakers during a Q&A session at the end of the news conference.

    Time/Date: Monday, August 1, at 10 a.m. Central Time (11 a.m. ET, 9 a.m. MT, 8 a.m. PT)

    Location: Austin Convention Center, Room 19B, 500 East Cesar Chavez Street, Austin, TX 78701

    To participate by telephone, call 888.872.2038 and enter guest code 1202#

    Please call a few minutes ahead.

    Interview Opportunities: The following plant disease experts will participate in the event.

  • Tim Gottwald, USDA Agriculture Research Service speaking on Citrus Canker
  • Caitilyn Allen, University of Wisconsin speaking on Bacterial Wilt
  • Vern Damsteegt, USDA Agriculture Research Service speaking on Plum Pox
  • Paul Tooley, USDA Agriculture Research Service - speaking on Sudden Oak Death
  • Matt Royer, USDA Animal and Plant Health Inspection Service (APHIS) speaking on Soybean Rust

    To receive background materials on these diseases, contact Amy Steigman at asteigman@scisoc.org or +1.651.994.3802.

    Members of the media are extended complimentary registration to APS annual meeting events. To register for the annual meeting, contact Amy Steigman.

    The American Phytopathological Society (APS) is a non-profit, professional scientific organization. The research
    '"/>



  • Contact: Amy Steigman
    asteigman@scisoc.org
    651-994-3802
    American Phytopathological Society
    20-Jul-2005


    Page: 1 2

    Related biology news :

    1. ESA mission highlighted at remote sensing conference
    2. News conference on plant diseases and issues important to California
    3. New Naval S&T Strategy to be detailed at partnership conference
    4. News conference announcing UA scientific initiative at Biosphere 2
    5. 18-year-old Singaporean student to present stem cell research paper at conferences in US and UK
    6. Invertebrate immune systems are anything but simple, conference finds
    7. Fibers are center stage at international conference
    8. 2007 Joint Assembly in Acapulco -- press conference schedule
    9. The Institute of Ecosystem Studies to host an international conference on ecology and urban design
    10. First international conference on self-healing materials
    11. Worlds top engineers in San Antonio for system of systems conference

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    TAG: News conference emerging plant diseases

    (Date:8/19/2015)...  VOXX International Corporation (Nasdaq: VOXX ) ... Definitive Agreement to purchase the assets, inclusive of ... EyeLock through an acquiring entity.  Upon consummation of ... in the acquiring entity. The closing of the ...  Expanding on its existing supply chain and distribution ...
    (Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
    (Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
    Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2
    (Date:9/2/2015)... -- Biovista Inc. is glad to announce ... science challenge, a global competition hosted by the Rare ... the latest life science innovations and technologies. ... capability to support Steven Laffoon and his ... Niemann-Pick Disease Type A (NPA), a rare and fatal ...
    (Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
    (Date:9/2/2015)... -- Aytu BioScience, Inc. (OTCQB: AYTU), a specialty healthcare ... conditions, announced today that it has closed the final ... raising a total of $5.175 million, which includes proceeds ... Josh Disbrow , Chief Executive Officer of ... to be used to conduct clinical studies for both ...
    (Date:9/2/2015)... , September 2, 2015 ... ("BioLight" or the "Company"), a firm that invests ... and cancer diagnostics, announced today that presentations highlighting ... will be delivered at the Ophthalmology Futures European ... Society of Cataract & Refractive Surgeons ("ESCRS"), both ...
    Breaking Biology Technology:Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
    Cached News: